Advertisement

Topics

One single biopsy not sufficient to guide treatment decisions in prostate cancer, say researchers

10:24 EDT 22 Sep 2016 | Science Daily

While the majority of prostate cancers are slow growing and not fatal, some are aggressive and lethal. Genomic fingerprinting can help predict a tumor's aggressiveness and tailor treatment plans, report researchers.

Original Article: One single biopsy not sufficient to guide treatment decisions in prostate cancer, say researchers

NEXT ARTICLE

More From BioPortfolio on "One single biopsy not sufficient to guide treatment decisions in prostate cancer, say researchers"

Quick Search
Advertisement